TSM10
Laboratory-grade research compound, prepared and packaged under controlled conditions. Not for human or animal consumption. For in vitro research use only.
Related compounds
Research Material Overview
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH), the endogenous hypothalamic peptide that stimulates growth hormone secretion. Tesamorelin incorporates an N-terminal trans-3-hexenoyl modification intended to enhance stability against enzymatic degradation relative to native GHRH. CloudComps supplies tesamorelin as a lyophilized research material for in vitro and laboratory investigation only.
Physical Description
Supplied as a white to off-white lyophilized powder in a sealed, sterile-capped glass vial. Handle under conditions that minimize moisture exposure. Reconstitute with an appropriate sterile, research-grade solvent prior to in vitro use.
Molecular Information
- Appearance
- White to off-white lyophilized powder
- Molecular formula
- C151H251N45O44
- Molecular weight
- ~3342 g/mol
- CAS number
- 106629-08-9
- Classification
- 44-amino-acid synthetic GHRH analog; hexenoyl-modified N-terminus
Purity & Testing Information
Reported purity of ≥ 99% is determined by RP-HPLC under the analytical conditions specified on the lot-specific Certificate of Analysis. Each lot is accompanied by chromatographic and mass spectrometry data. Researchers should evaluate the complete analytical documentation, as a purity percentage alone does not establish identity or exclude all impurities.
Available Documentation
- Lot-specific Certificate of Analysis (COA)
- RP-HPLC chromatogram with purity calculation
- Mass spectrometry (LC-MS) data
- Solubility and reconstitution guidance
- Storage and handling documentation
Storage Information
Store lyophilized material at -20°C, protected from light and moisture, in the original sealed vial. After reconstitution, aliquot and store at 2-8°C for short-term use or -20°C for longer storage. Avoid repeated freeze-thaw cycles. Stability under specific experimental conditions should be verified by the researcher.
Frequently Asked Questions
How does tesamorelin differ from native GHRH?
Tesamorelin is a synthetic analog of growth hormone-releasing hormone that incorporates an N-terminal hexenoyl modification. This modification is intended to increase resistance to enzymatic degradation compared with the endogenous peptide, which is the basis for its characterization in research models.
Is tesamorelin intended for human use?
No. The material supplied by CloudComps is for in vitro laboratory and scientific research only and is not for human or veterinary consumption.
Why is storage temperature important for this peptide?
Peptides can undergo degradation depending on storage and handling conditions. Maintaining the lyophilized material at -20°C and minimizing freeze-thaw cycles after reconstitution helps preserve the integrity of the material for laboratory use.
Related Research Resources
Research-Use Disclaimer
Tesamorelin is intended exclusively for in vitro laboratory and scientific research purposes. It is not for human or veterinary consumption, clinical use, or diagnostic application. Researchers should review the complete analytical documentation, handle the material in accordance with appropriate laboratory practices, and comply with all applicable regulations. Statements regarding receptor activity or research interest refer to preclinical study contexts and do not imply suitability for any particular application.